These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Collin N; de Radiguès X; Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891 [TBL] [Abstract][Full Text] [Related]
23. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ; ; ; ; ; ; ; ; ; ; J Am Coll Cardiol; 2006 Oct; 48(7):1498-502. PubMed ID: 17010820 [TBL] [Abstract][Full Text] [Related]
24. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041 [TBL] [Abstract][Full Text] [Related]
26. [Problems of influenza vaccination]. Sabin AB Fortschr Med; 1981 Sep; 99(34):1327-31. PubMed ID: 7286877 [TBL] [Abstract][Full Text] [Related]
27. Use of antiviral agents and other measures in an influenza pandemic. Groeneveld K; van der Noordaa J Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380 [TBL] [Abstract][Full Text] [Related]
28. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis]. Machała MK; Brydak LB Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191 [TBL] [Abstract][Full Text] [Related]
29. Influenza and influenza vaccination. Goodman RA; Hinman AR; Nolan TF; Brandling-Bennett AD Am Fam Physician; 1980 Jan; 21(1):101-5. PubMed ID: 7350730 [TBL] [Abstract][Full Text] [Related]
30. Vaccines in the prevention of viral pneumonia. Betts RF Semin Respir Infect; 1995 Dec; 10(4):282-7. PubMed ID: 8668856 [TBL] [Abstract][Full Text] [Related]
31. Developing vaccines against pandemic influenza. Wood JM Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1953-60. PubMed ID: 11779397 [TBL] [Abstract][Full Text] [Related]
32. Conceptional considerations for a German influenza pandemic preparedness plan. Fock R; Bergmann H; Bussmann H; Fell G; Finke EJ; Koch U; Niedrig M; Peters M; Scholz D; Wirtz A Med Microbiol Immunol; 2002 Dec; 191(3-4):191-5. PubMed ID: 12458359 [TBL] [Abstract][Full Text] [Related]
33. [Vaccination against influenza--why, for whom and with which vaccine?]. Bergsaker M; Hungnes O; Iversen B Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2814-7. PubMed ID: 17086223 [TBL] [Abstract][Full Text] [Related]
34. Influenza: current evidence and informed predictions. Handa R; Teo S; Booy R Expert Rev Vaccines; 2004 Aug; 3(4):443-51. PubMed ID: 15270649 [TBL] [Abstract][Full Text] [Related]
35. Preparing for a possible pandemic: influenza A/H5N1 vaccine development. Keitel WA; Atmar RL Curr Opin Pharmacol; 2007 Oct; 7(5):484-90. PubMed ID: 17644429 [TBL] [Abstract][Full Text] [Related]
36. Influenza vaccine with squalene adjuvant: new preparation. No better than available products. Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987 [TBL] [Abstract][Full Text] [Related]
37. Influenza: current concepts. Dolin R Am Fam Physician; 1976 Sep; 14(3):72-7. PubMed ID: 961563 [TBL] [Abstract][Full Text] [Related]
38. The use of amantadine and influenza vaccine in a type A influenza epidemic in a boarding school. Rose HJ J R Coll Gen Pract; 1980 Oct; 30(219):619-21. PubMed ID: 7452602 [TBL] [Abstract][Full Text] [Related]